DenClude

DenClude is an early-stage biotechnology company focused on developing innovative treatments for dentin hypersensitivity. The company's core technology is an in-situ forming hydrogel designed to provide long-lasting relief by effectively sealing exposed dentinal tubules. Unlike traditional treatments that are easily washed away, DenClude's platform aims to offer a durable barrier that resists mechanical and chemical challenges in the oral environment. By targeting the root cause of tooth sensitivity, the company seeks to improve the quality of life for millions of patients suffering from sharp dental pain. DenClude is currently advancing its lead candidate through pre-clinical development to establish safety and efficacy for future clinical applications.